Skip to content
GLP-1 Scorecard
Menu

Evidence review

Is Compounded Semaglutide Legit and Safe?

Check the prescriber, dispensing pharmacy, formulation, and follow-up before considering compounded semaglutide.

Published by GLP-1 Scorecard
On this page

A provider's legitimacy, a preparation's legal status, and its safety are different questions. A professional website or low price cannot answer all three. This checklist helps you gather evidence to discuss with a licensed clinician; it cannot certify a product as safe.

Start with the treatment decision

Compounded drugs are not FDA-approved: FDA does not review each preparation for safety, effectiveness, or quality before marketing. Compounding can address a medical need an approved drug cannot meet; it should not be treated as an interchangeable generic of an approved product.1 Ask your clinician why the proposed formulation is appropriate for you and whether an approved option can meet that need.

Check who prescribes and who dispenses

Get the prescriber's name and the dispensing pharmacy's legal name, address, and contact information. Verify the relevant licenses directly using our pharmacy verification steps. Keep the results with the date checked. A provider's badge, testimonial, or statement that it works with licensed pharmacies is not a substitute for identifying your pharmacy.

Ask who will respond to treatment questions, how to contact them, and what happens outside normal hours. Before paying, find out whether a change in pharmacy will be disclosed. These are questions about accountability, not proof that adverse effects cannot occur.

Identify the actual formulation

Ask for the active ingredient, concentration, added ingredients, and dosage form. FDA distinguishes semaglutide salt forms from the ingredient used in approved drugs and says it is unaware of a lawful basis for their use in compounding.2 Do not infer that a preparation has the same evidence as an approved injection merely because the seller uses the word semaglutide.

If you are choosing a seller, our System Labs review, our Eden review, and our MyDrHank review set out the prices, renewal terms and what we could not verify for each. All of these sellers pay us a commission when a reader signs up, which never changes a grade.

For a supplied vial, use the label checklist to collect the details for the pharmacist. Do not convert syringe units or reconstruct missing instructions from an internet example. If the product arrives warm, follow the shipment response guide and obtain product-specific instructions before use.

Ask about the present regulatory basis

The shortage-rule explainer separates 503A and 503B requirements. Neither the phrase patient-specific nor a changed concentration is enough for this site to judge a prescription lawful. Ask the prescriber and pharmacy to explain the actual basis, rather than relying on old shortage marketing.

Keep approval, safety, and price separate

FDA has reported problems with unapproved GLP-1 products, including dosing errors and fraudulent labeling.2 A named, licensed pharmacy is one check, not a guarantee against those problems. The clinician still needs to assess your history, other medicines, and monitoring needs.

If cost is the obstacle, discuss approved coverage and cash-payment options before assuming compounding is the only path. Our brand versus compounded comparison explains the product distinction, while the six-month cost guide helps separate medication, membership, and visit charges. No ranking or provider grade replaces that clinical assessment.

Sources and wording were rechecked October 6, 2026. This revision removes the earlier implication that a compounded product necessarily clears a legal threshold or that transparency establishes safety.

Frequently asked questions

Is compounded semaglutide FDA-approved?

No. Compounded preparations do not receive the individual FDA approval held by approved drug products.

Does a licensed pharmacy guarantee safety?

No. Verify the pharmacy, but also have the prescriber assess the actual formulation and your medical needs. Licensure is one check, not a product safety guarantee.

References

  1. U.S. Food and Drug Administration (2026). Compounding and the FDA: Questions and Answers. FDA.gov (accessed October 6, 2026). Read source
  2. U.S. Food and Drug Administration (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA.gov (accessed October 6, 2026). Read source

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.